Trial Profile

Part A, B and D: A 4-Part Dose-Escalation, Food Effect, And Drug-Drug Interaction Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of SGR-1505 In Healthy Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 21 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SGR-1505 (Primary) ; Posaconazole
Indications B-cell lymphoma; Diffuse large B cell lymphoma
Focus Adverse reactions; First in man; Pharmacodynamics
Sponsors Schrodinger

Most Recent Events

28 Dec 2023 Not adding 74 as actual patient count as trial status is not clear from this source (9406020).
14 Dec 2023 Acording to a Schrodinger media release, the company will present data from this study during its Pipeline Day today, December 14, from 10:00 a.m. - 12:30 p.m. ET.
14 Dec 2023 Results presented in a Schrodinger media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com